Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
Since May 16, 2024, Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has reported earnings 9 times. On average the shares move ±4.68% post-earnings, with a positive reaction 100.0% of the time. Its largest post-earnings gain was +8.27% (Aug 13, 2024) and its largest decline was +0.25% (Mar 05, 2026). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
9
Avg Abs. Movement
±4.68%
Positive %
100.0%
Negative %
0.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 05, 2026 | ☽ POST | $14.44 | $14.47 | $14.38 | 9,495 | +3.62% | open_in_new |
| Mar 05, 2026 | ☽ POST | $13.62 | $13.88 | $13.86 | 23,768 | +0.25% | open_in_new |
| Oct 30, 2025 | ☽ POST | $10.79 | $10.82 | $10.54 | 1,430 | +4.41% | open_in_new |
| Aug 05, 2025 | ☽ POST | $5.75 | $6.07 | $6.00 | 6,870 | +6.33% | open_in_new |
| May 14, 2025 | ☽ POST | $3.98 | $3.98 | $3.85 | 6,889 | +2.73% | open_in_new |
| Mar 06, 2025 | ☽ POST | $6.41 | $6.61 | $6.39 | 1,578 | +6.1% | open_in_new |
| Nov 06, 2024 | ☽ POST | $17.52 | $17.53 | $17.15 | 3,853 | +8.16% | open_in_new |
| Aug 13, 2024 | ☽ POST | $16.62 | $16.62 | $16.62 | 389 | +8.27% | open_in_new |
| May 16, 2024 | ☽ POST | $15.33 | $15.34 | $15.14 | 1,640 | +2.21% | open_in_new |
Earnings Count
9
Total earnings in dataset
Avg Abs. Movement
±4.68%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
4 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260601 | open_in_new SEC.gov |
| 4 | 20260601 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260515 | open_in_new SEC.gov |
Frequently asked about CTNM earnings
When does Contineum Therapeutics, Inc. Class A Common Stock report earnings next? expand_more
Contineum Therapeutics, Inc. Class A Common Stock (CTNM)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CTNM stock move after earnings? expand_more
Over 9 reports, CTNM has moved an average of ±4.68% the session after earnings, closing higher 100.0% of the time.
What was CTNM's biggest post-earnings move? expand_more
CTNM's largest post-earnings gain on record was +8.27% on Aug 13, 2024, and its largest decline was +0.25% on Mar 05, 2026.
Where can I find Contineum Therapeutics, Inc. Class A Common Stock's SEC filings? expand_more
All of Contineum Therapeutics, Inc. Class A Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right